Heterogeneity in tuberculosis pathology, microenvironments and therapeutic responses
- PMID: 25703567
- PMCID: PMC4368385
- DOI: 10.1111/imr.12252
Heterogeneity in tuberculosis pathology, microenvironments and therapeutic responses
Abstract
Tuberculosis (TB) lesions are extremely complex and dynamic. Here, we review the multiple types and fates of pulmonary lesions that form following infection by Mycobacterium tuberculosis and the impact of this spatial and temporal heterogeneity on the bacteria they harbor. The diverse immunopathology of granulomas and cavities generates a plethora of microenvironments to which M. tuberculosis bacilli must adapt. This in turn affects the replication, metabolism, and relative density of bacterial subpopulations, and consequently their respective susceptibility to chemotherapy. We outline recent developments that support a paradigm shift in our understanding of lesion progression. The simple model according to which lesions within a single individual react similarly to the systemic immune response no longer prevails. Host-pathogen interactions within lesions are a dynamic process, driven by subtle and local differences in signaling pathways, resulting in diverging trajectories of lesions within a single host. The spectrum of TB lesions is a continuum with a large overlap in the lesion types found in latently infected and active TB patients. We hope this overview will guide TB researchers in the design, choice of read-outs, and interpretation of future studies in the search for predictive biomarkers and novel therapies.
Keywords: animal models; biomarkers; immunopathology; lesion dynamics; tuberculosis.
© 2015 The Authors. Immunological Reviews Published by John Wiley & Sons Ltd.
Figures



Similar articles
-
Heterogeneity in tuberculosis.Nat Rev Immunol. 2017 Nov;17(11):691-702. doi: 10.1038/nri.2017.69. Epub 2017 Jul 24. Nat Rev Immunol. 2017. PMID: 28736436 Free PMC article. Review.
-
Mouse models of human TB pathology: roles in the analysis of necrosis and the development of host-directed therapies.Semin Immunopathol. 2016 Mar;38(2):221-37. doi: 10.1007/s00281-015-0538-9. Epub 2015 Nov 5. Semin Immunopathol. 2016. PMID: 26542392 Free PMC article. Review.
-
Characterization of host and microbial determinants in individuals with latent tuberculosis infection using a human granuloma model.mBio. 2015 Feb 17;6(1):e02537-14. doi: 10.1128/mBio.02537-14. mBio. 2015. PMID: 25691598 Free PMC article.
-
Host-directed therapy targeting the Mycobacterium tuberculosis granuloma: a review.Semin Immunopathol. 2016 Mar;38(2):167-83. doi: 10.1007/s00281-015-0537-x. Epub 2015 Oct 28. Semin Immunopathol. 2016. PMID: 26510950 Free PMC article. Review.
-
TB drug development: immunology at the table.Immunol Rev. 2015 Mar;264(1):308-18. doi: 10.1111/imr.12275. Immunol Rev. 2015. PMID: 25703568 Free PMC article. Review.
Cited by
-
Bedaquiline and Pyrazinamide Treatment Responses Are Affected by Pulmonary Lesion Heterogeneity in Mycobacterium tuberculosis Infected C3HeB/FeJ Mice.ACS Infect Dis. 2016 Apr 8;2(4):251-267. doi: 10.1021/acsinfecdis.5b00127. Epub 2016 Feb 24. ACS Infect Dis. 2016. PMID: 27227164 Free PMC article.
-
The tryptophan biosynthetic pathway is essential for Mycobacterium tuberculosis to cause disease.Biochem Soc Trans. 2020 Oct 30;48(5):2029-2037. doi: 10.1042/BST20200194. Biochem Soc Trans. 2020. PMID: 32915193 Free PMC article. Review.
-
Agent-based model predicts that layered structure and 3D movement work synergistically to reduce bacterial load in 3D in vitro models of tuberculosis granuloma.PLoS Comput Biol. 2024 Jul 12;20(7):e1012266. doi: 10.1371/journal.pcbi.1012266. eCollection 2024 Jul. PLoS Comput Biol. 2024. PMID: 38995971 Free PMC article.
-
Longer-Term Omega-3 LCPUFA More Effective Adjunct Therapy for Tuberculosis Than Ibuprofen in a C3HeB/FeJ Tuberculosis Mouse Model.Front Immunol. 2021 Apr 28;12:659943. doi: 10.3389/fimmu.2021.659943. eCollection 2021. Front Immunol. 2021. PMID: 33995381 Free PMC article.
-
Tools to develop antibiotic combinations that target drug tolerance in Mycobacterium tuberculosis.Front Cell Infect Microbiol. 2023 Jan 6;12:1085946. doi: 10.3389/fcimb.2022.1085946. eCollection 2022. Front Cell Infect Microbiol. 2023. PMID: 36733851 Free PMC article. Review.
References
-
- Barnes DS. The Making of a Social Disease – Tuberculosis in Nineteenth-Century France. Berkeley, Los Angeles, London: University of California Press; 1995.
-
- Canetti G. The Tubercle Bacillus. New York: Springer Publishing COmpany; 1955.
-
- Dannenberg AM., Jr . Pathogenesis of Human Pulmonary Tuberculosis. Washington, DC: ASM Press; 2006.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical